This discussion reviews the currently available antivirals and recommendations for their use in influenza prophylaxis and treatment. Because our understanding of 2009 H1N1 influenza is still evolving, some off-label use of medications is discussed and noted. Information on 2009 H1N1 is updated frequently, andreaders are encouraged to monitor advisories from federal, state, and local health agencies for up-to-date information. (Drug Benefit Trends. 2010;22:10-14)
More »H1N1 influenza has paid an unwelcome visit to a number of nursing homes, reports the CDC.
More »MedImmune is recalling 13 lots of monovalent 2009 H1N1 influenza nasal spray vaccine whose potency has decreased or is expected to decrease shortly.
More »A single dose of 2009 influenza A (H1N1) vaccine induced protective antibody titers in more than 90% of children in an Australian study.
More »Sanofi Pasteur is recalling 4 lots of pediatric H1N1 vaccine in 0.25 mL pre-filled syringes because of concerns about potency.
More »
Showing 1 - 5 of 32 results.